Document is current
Any future updates will be listed below
-
Authors
Ma, Xin https://orcid.org/0009-0009-3347-4257
Shedlock, Cameron J.
Medina, Terrymar
Ribas, Roberto A. https://orcid.org/0009-0008-9024-1292
Clarke, Harrison A.
Hawkinson, Tara R. https://orcid.org/0000-0002-8743-5503
Dande, Praveen K.
Golamari, Hari K. R.
Wu, Lei https://orcid.org/0000-0002-1474-8082
Ziani, Borhane EC.
Burke, Sara N.
Merritt, Matthew E. https://orcid.org/0000-0003-4617-9651
Vander Kooi, Craig W.
Gentry, Matthew S. https://orcid.org/0000-0001-5253-9049
Yadav, Nirbhay N.
Chen, Li https://orcid.org/0000-0001-9372-5606
Sun, Ramon C. https://orcid.org/0000-0002-3009-1850
- License Information
-
More Information
Article History
Received: 11 January 2024
Accepted: 10 February 2025
First Online: 18 March 2025
Competing interests
: R.C.S. has research support and received consultancy fees from Maze Therapeutics. R.C.S. is a member of the Medical Advisory Board for Little Warrior Foundation. M.S.G. received research support and research compounds from Maze Therapeutics, Valerion Therapeutics and Ionis Pharmaceuticals. M.S.G. also received a consultancy fee from Maze Therapeutics, PTC Therapeutics and the Glut1-Deficiency Syndrome Foundation. The other authors declare no competing interests.
